Millipore Sigma Vibrant Logo

208733 Calpain Inhibitor Set - Calbiochem

The Calpain Inhibitor Set controls the biological activity of Calpain. This small molecule/inhibitor is primarily used for Protease Inhibitors applications.

Calpain Inhibitor Set - Calbiochem: MSDS (material safety data sheet) o SDS, certificato d’analisi (CoA) e certificato di qualità (CoQ), dossier, brochure e altri documenti disponibili.
Primary Target: calpain 1, calpain 2
View Products on Sigmaaldrich.com
208733
Visualizza prezzi e disponibilità

Panoramica

Replacement Information

Prezzi e disponibilità

Numero di catalogo DisponibilitàConfezionamento Qtà/conf Prezzo Quantità
208733-1SET
Verifica della disponibilità in corso...
—
Disponibilità limitata Disponibilità limitata
A magazzino 
Fuori produzione
Disponibili quantità limitate
La disponibilità deve essere confermata
    Prodotti rimanenti: riceverà un nostro avviso
      Prodotti rimanenti: riceverà un nostro avviso
      Will advise
      Contatti il Servizio Clienti
      Contact Customer Service

      		 Bottiglia di vetro 1 set
      Ricerca del prezzo in corso...
      Non è stato possibile trovare il prezzo
      La quantità minima deve essere un multiplo di
      Maximum Quantity is
      Al termine dell'ordine Maggiori informazioni
      Lei ha salvato ()
       
      —
      Richiedi il prezzo
      		 —
      Description
      OverviewContains 5 mg of ALLN (Cat. No. 208719), 25 mg of Calpain Inhibitor III (Cat. No. 208722), 5 mg of Calpeptin (Cat. No. 03-34-0051), 1 mg of EST (Cat. No. 330005), and 5 mg of PD 150606 (Cat. No. 513022).
      Catalogue Number208733
      Brand Family Calbiochem®
      References
      ReferencesJohnson, G.V.W., and Guttmann, R.P. 1997. BioEssays 19, 1011.
      Kampfl, A., et al. 1997. J. Neurotauma 14, 121.
      Sorimachi, H., et al., 1997. Biochem. J. 328, 721.
      Bartus, R.T., et al. 1995. Neurol. Res. 17, 249.
      Wang, K.K.W., and Yuen, P-W. 1994. Trends Pharmacol. Sci. 15, 412.
      Saito, K., et al. 1993. Proc. Natl. Acad. Sci. USA 90, 2628.
      Goll, D.E., et al. 1992. BioEssays 14, 549.
      Product Information
      FormSolid
      ReversibleN
      Quality LevelMQ100
      Applications
      Biological Information
      Primary Targetcalpain 1, calpain 2
      Primary Target K<sub>i</sub>8 nM
      Physicochemical Information
      Cell permeableY
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      R PhraseR: 36/37/38

      Irritating to eyes, respiratory system and skin.
      S PhraseS: 26-36

      In case of contact with eyes, rinse immediately with plenty of water and seek medical advice.
      Wear suitable protective clothing.
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Ambient Temperature Only
      Toxicity Multiple Toxicity Values, refer to MSDS
      Storage -20°C
      Protect from Light Protect from light
      Protect from Moisture Protect from moisture
      Do not freeze Ok to freeze
      Packaging Information
      Packaged under inert gas Packaged under inert gas
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      Numero di catalogo GTIN
      208733-1SET 04055977202755

      Documentation

      Calpain Inhibitor Set - Calbiochem MSDS

      Titolo

      Scheda di sicurezza (MSDS) 

      Calpain Inhibitor Set - Calbiochem Certificati d'Analisi

      TitoloNumero di lotto
      208733

      Riferimenti bibliografici

      Panoramica delle referenze
      Johnson, G.V.W., and Guttmann, R.P. 1997. BioEssays 19, 1011.
      Kampfl, A., et al. 1997. J. Neurotauma 14, 121.
      Sorimachi, H., et al., 1997. Biochem. J. 328, 721.
      Bartus, R.T., et al. 1995. Neurol. Res. 17, 249.
      Wang, K.K.W., and Yuen, P-W. 1994. Trends Pharmacol. Sci. 15, 412.
      Saito, K., et al. 1993. Proc. Natl. Acad. Sci. USA 90, 2628.
      Goll, D.E., et al. 1992. BioEssays 14, 549.

      Brochure

      Titolo
      Caspases and other Apoptosis Related Tools Brochure
      Scheda tecnica

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision28-May-2008 RFH
      DescriptionCalpains are a family of calcium-dependent thiol-proteases that act on a wide variety of cytoskeletal, membrane-associated, and regulatory proteins. There are two major isoforms: calpain I (µ-form) and calpain II (m-form), which differ in their calcium requirement for activation Calpains are composed of heterodimers of 80 kDa and a 30 kDa subunits. The 80 kDa unit has the catalytic site and is unique to each isozyme, whereas the 30 kDa unit is the regulatory subunit and is common to both µ- and m-isozymes.

      More recently, attention has been focused on the pathological significance of calcium accumulation in the central nervous system following cerebral ischemia and traumatic brain injury. Over-activation of NMDA, kainate, and AMPA receptors in the brain leads to sustained influx of Ca2+ through the voltage-gated calcium channels. Overexpression of calpains has been positively linked to both acute and chronic neurodegenerative processes including ischemia, trauma, and Alzheimer's disease. In Alzheimer's disease the ratio of active (76 kDa) to inactive (80 kDa) µ-calpain is reported to be much higher Calpain-dependent proteolysis is usually the late-stage common pathway towards cell death induced by excitotoxic compounds, hence, a selective inhibition of calpains to limit neuronal damage appears to be a viable therapeutic measure.
      FormSolid
      Intert gas (Yes/No) Packaged under inert gas
      Storage Protect from moisture
      Protect from light
      -20°C
      Do Not Freeze Ok to freeze
      Toxicity Multiple Toxicity Values, refer to MSDS
      ReferencesJohnson, G.V.W., and Guttmann, R.P. 1997. BioEssays 19, 1011.
      Kampfl, A., et al. 1997. J. Neurotauma 14, 121.
      Sorimachi, H., et al., 1997. Biochem. J. 328, 721.
      Bartus, R.T., et al. 1995. Neurol. Res. 17, 249.
      Wang, K.K.W., and Yuen, P-W. 1994. Trends Pharmacol. Sci. 15, 412.
      Saito, K., et al. 1993. Proc. Natl. Acad. Sci. USA 90, 2628.
      Goll, D.E., et al. 1992. BioEssays 14, 549.